Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 25%GRADE not reported 0 · 0%Very low 2 · 50%Low 1 · 25%Moderate 0 · 0%High 0 · 0%

Myo‐inositol vs D‐chiro‐inositol

Adverse event ‐ multiple pregnancy · subfertile women with polycystic ovary syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Myo‐inositol vs clomiphene

Adverse event ‐ multiple pregnancy · subfertile women with polycystic ovary syndrome

It is very uncertain whether myo‐inositol changes adverse event ‐ multiple pregnancy compared with an ovulation induction agent (clomiphene) (very low certainty).

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
OR 0.21 [0.01, 4.43]
1 study · 75 participants
Very low

Myo‐inositol vs Placebo, no intervention or usual care (with or without placebo)

Adverse event ‐ multiple pregnancy · subfertile women with polycystic ovary syndrome

Myo‐inositol showed no clear difference in adverse event ‐ multiple pregnancy compared with placebo, no/standard treatment (low certainty).

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
OR 1.04 [0.63, 1.71]
2 studies · 425 participants
Low

Myo‐inositol vs antioxidant (melatonin)

Adverse event ‐ multiple pregnancy · subfertile women with polycystic ovary syndrome

It is very uncertain whether myo‐inositol changes adverse event ‐ multiple pregnancy compared with antioxidant (melatonin) (very low certainty).

1 finding from 1 review

Inositol for subfertile women with polycystic ovary syndrome 2018 · Cochrane Headline outcomes only
OR 0.95 [0.57, 1.59]
1 study · 358 participants
Very low